Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-01-24 @ 10:35 PM
Study NCT ID:
NCT04239092
Status:
TERMINATED
Last Update Posted:
2025-07-17
First Post:
2020-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
9-ING-41 in Pediatric Patients With Refractory Malignancies.
Sponsor:
Actuate Therapeutics Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Refractory Cancer | View |
| None | Refractory Neoplasm | View |
| None | Cancer Pediatric | View |
| None | Refractory Tumor | View |
| None | Pediatric Cancer | View |
| None | Pediatric Brain Tumor | View |
| None | Neuroblastoma | View |
| None | Neuroblastoma Recurrent | View |
| None | Pediatric Lymphoma | View |
| None | Pediatric Meningioma | View |
| None | Diffuse Intrinsic Pontine Glioma | View |